Industry: Chemical & Material
Published Date: 2026-07-09
Pages: 132 Pages
Report ld: 6863227
Request Sample
Customized Report
Dihydropyridine (DHP) Market Size(US$)

CAGR 2026-2032
4.2%
Market Size,2032
USD 18.03
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Dihydropyridine (DHP) was estimated to be worth US$ 13.57 million in 2025 and is projected to reach US$ 18.03 million, growing at a CAGR of 4.2% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Dihydropyridine (DHP) cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Dihydropyridine (DHP) is a molecule based on pyridine, which is a six-membered ring with one nitrogen atom. DHP has two hydrogen atoms replacing one double bond in the ring, making it partially saturated. DHP is the parent of a class of molecules that have various substituents attached to the ring, and are widely used as L-type calcium channel blockers, which are medications that block the entry of calcium ions into the muscle cells of the heart and blood vessels, thereby lowering blood pressure and treating various cardiovascular diseases.
The future market trends of DHP are influenced by several factors, such as the demand for its downstream products, the availability and price of raw materials, the environmental and regulatory policies, and the technological innovations. Some of the key trends are:The demand for DHP is expected to increase in the pharmaceutical sector, as it is used as a precursor for the synthesis of various drugs, such as anti-inflammatory, antiviral, antifungal, and anticancer agents. The increasing prevalence of chronic and infectious diseases, the aging population, and the health expenditure are expected to boost the demand for these drugs.The availability and price of raw materials, such as 2-Chloro-5-nitropyridine and methanol, are important factors that affect the production and cost of DHP. The fluctuations in the supply and demand of these raw materials, as well as the geopolitical and economic conditions, can have a significant impact on the market trends of DHP.The environmental and regulatory policies are also influencing the market trends of DHP. As this compound is classified as a hazardous substance, it is subject to strict regulations and standards for its handling, storage, transportation, and disposal. The producers and consumers of DHP have to comply with these regulations and standards, which can affect the market dynamics and profitability .The technological innovations are also shaping the market trends of DHP. The development of new and improved methods for the synthesis, purification, and analysis of DHP can enhance the quality, efficiency, and safety of the production process. The emergence of novel and alternative applications of DHP can also create new market opportunities and challenges .
This report provides a comprehensive view of the global market for Dihydropyridine (DHP), covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Dihydropyridine (DHP) market size, estimations, and forecasts are presented in terms of sales volume (MT) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Dihydropyridine (DHP).
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Dihydropyridine (DHP) manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Dihydropyridine (DHP) sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Dihydropyridine (DHP) sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Dihydropyridine (DHP) Product Introduction
1.2 Global Dihydropyridine (DHP) Market Size Forecast
1.2.1 Global Dihydropyridine (DHP) Sales Value (2021–2032)
1.2.2 Global Dihydropyridine (DHP) Sales Volume (2021–2032)
1.2.3 Global Dihydropyridine (DHP) Sales Price (2021–2032)
1.3 Dihydropyridine (DHP) Market Trends & Drivers
1.3.1 Dihydropyridine (DHP) Industry Trends
1.3.2 Dihydropyridine (DHP) Market Drivers & Opportunities
1.3.3 Dihydropyridine (DHP) Market Challenges
1.3.4 Dihydropyridine (DHP) Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Dihydropyridine (DHP) Players Revenue Ranking (2025)
2.2 Global Dihydropyridine (DHP) Revenue by Company (2021–2026)
2.3 Global Dihydropyridine (DHP) Sales Volume Ranking of Players (2025)
2.4 Global Dihydropyridine (DHP) Sales Volume by Company (2021–2026)
2.5 Global Dihydropyridine (DHP) Average Price by Company (2021–2026)
2.6 Key Manufacturers Dihydropyridine (DHP) Manufacturing Base and Headquarters
2.7 Key Manufacturers Dihydropyridine (DHP) Product Offerings
2.8 Key Manufacturers Start of Mass Production of Dihydropyridine (DHP)
2.9 Dihydropyridine (DHP) Market Competitive Analysis
2.9.1 Dihydropyridine (DHP) Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Dihydropyridine (DHP) Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Dihydropyridine (DHP) revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Dihydropyridine (DHP) Market Classification
3.1 Introduction by Type
3.1.1 Purity 98%
3.1.2 Purity 99%
3.1.3 Others
3.1.4 Global Dihydropyridine (DHP) Sales Value by Type
3.1.4.1 Global Dihydropyridine (DHP) Sales Value by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Dihydropyridine (DHP) Sales Value, by Type (2021–2032)
3.1.4.3 Global Dihydropyridine (DHP) Sales Value, by Type (%), 2021–2032
3.1.5 Global Dihydropyridine (DHP) Sales Volume by Type
3.1.5.1 Global Dihydropyridine (DHP) Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global Dihydropyridine (DHP) Sales Volume, by Type (2021–2032)
3.1.5.3 Global Dihydropyridine (DHP) Sales Volume, by Type (%), 2021–2032
3.1.6 Global Dihydropyridine (DHP) Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical
4.1.2 Veterinary Drugs
4.1.3 Others
4.2 Global Dihydropyridine (DHP) Sales Value by Application
4.2.1 Global Dihydropyridine (DHP) Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Dihydropyridine (DHP) Sales Value, by Application (2021–2032)
4.2.3 Global Dihydropyridine (DHP) Sales Value, by Application (%), 2021–2032
4.3 Global Dihydropyridine (DHP) Sales Volume by Application
4.3.1 Global Dihydropyridine (DHP) Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Dihydropyridine (DHP) Sales Volume, by Application (2021–2032)
4.3.3 Global Dihydropyridine (DHP) Sales Volume, by Application (%), 2021–2032
4.4 Global Dihydropyridine (DHP) Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Dihydropyridine (DHP) Sales Value by Region
5.1.1 Global Dihydropyridine (DHP) Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Dihydropyridine (DHP) Sales Value by Region (2021–2026)
5.1.3 Global Dihydropyridine (DHP) Sales Value by Region (2027–2032)
5.1.4 Global Dihydropyridine (DHP) Sales Value by Region (%), 2021–2032
5.2 Global Dihydropyridine (DHP) Sales Volume by Region
5.2.1 Global Dihydropyridine (DHP) Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Dihydropyridine (DHP) Sales Volume by Region (2021–2026)
5.2.3 Global Dihydropyridine (DHP) Sales Volume by Region (2027–2032)
5.2.4 Global Dihydropyridine (DHP) Sales Volume by Region (%), 2021–2032
5.3 Global Dihydropyridine (DHP) Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Dihydropyridine (DHP) Sales Value, 2021–2032
5.4.2 North America Dihydropyridine (DHP) Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Dihydropyridine (DHP) Sales Value, 2021–2032
5.5.2 Europe Dihydropyridine (DHP) Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Dihydropyridine (DHP) Sales Value, 2021–2032
5.6.2 Asia Pacific Dihydropyridine (DHP) Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Dihydropyridine (DHP) Sales Value, 2021–2032
5.7.2 South America Dihydropyridine (DHP) Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Dihydropyridine (DHP) Sales Value, 2021–2032
5.8.2 Middle East & Africa Dihydropyridine (DHP) Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Dihydropyridine (DHP) Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Dihydropyridine (DHP) Sales Value and Sales Volume
6.2.1 Key Countries/Regions Dihydropyridine (DHP) Sales Value, 2021–2032
6.2.2 Key Countries/Regions Dihydropyridine (DHP) Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Dihydropyridine (DHP) Sales Value, 2021–2032
6.3.2 United States Dihydropyridine (DHP) Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Dihydropyridine (DHP) Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Dihydropyridine (DHP) Sales Value, 2021–2032
6.4.2 Europe Dihydropyridine (DHP) Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Dihydropyridine (DHP) Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Dihydropyridine (DHP) Sales Value, 2021–2032
6.5.2 China Dihydropyridine (DHP) Sales Value by Type (%), 2025 vs 2032
6.5.3 China Dihydropyridine (DHP) Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Dihydropyridine (DHP) Sales Value, 2021–2032
6.6.2 Japan Dihydropyridine (DHP) Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Dihydropyridine (DHP) Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Dihydropyridine (DHP) Sales Value, 2021–2032
6.7.2 South Korea Dihydropyridine (DHP) Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Dihydropyridine (DHP) Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Dihydropyridine (DHP) Sales Value, 2021–2032
6.8.2 Southeast Asia Dihydropyridine (DHP) Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Dihydropyridine (DHP) Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Dihydropyridine (DHP) Sales Value, 2021–2032
6.9.2 India Dihydropyridine (DHP) Sales Value by Type (%), 2025 vs 2032
6.9.3 India Dihydropyridine (DHP) Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Shenzhen Simeiquan Biotechnology
7.1.1 Shenzhen Simeiquan Biotechnology Company Information
7.1.2 Shenzhen Simeiquan Biotechnology Introduction and Business Overview
7.1.3 Shenzhen Simeiquan Biotechnology Dihydropyridine (DHP) Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Shenzhen Simeiquan Biotechnology Dihydropyridine (DHP) Product Offerings
7.1.5 Shenzhen Simeiquan Biotechnology Recent Developments
7.2 Boc Sciences
7.2.1 Boc Sciences Company Information
7.2.2 Boc Sciences Introduction and Business Overview
7.2.3 Boc Sciences Dihydropyridine (DHP) Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Boc Sciences Dihydropyridine (DHP) Product Offerings
7.2.5 Boc Sciences Recent Developments
7.3 Weifang Union Biochemistry
7.3.1 Weifang Union Biochemistry Company Information
7.3.2 Weifang Union Biochemistry Introduction and Business Overview
7.3.3 Weifang Union Biochemistry Dihydropyridine (DHP) Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Weifang Union Biochemistry Dihydropyridine (DHP) Product Offerings
7.3.5 Weifang Union Biochemistry Recent Developments
7.4 Angene International Limited
7.4.1 Angene International Limited Company Information
7.4.2 Angene International Limited Introduction and Business Overview
7.4.3 Angene International Limited Dihydropyridine (DHP) Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Angene International Limited Dihydropyridine (DHP) Product Offerings
7.4.5 Angene International Limited Recent Developments
7.5 Triveni Chemicals
7.5.1 Triveni Chemicals Company Information
7.5.2 Triveni Chemicals Introduction and Business Overview
7.5.3 Triveni Chemicals Dihydropyridine (DHP) Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Triveni Chemicals Dihydropyridine (DHP) Product Offerings
7.5.5 Triveni Chemicals Recent Developments
7.6 Yuyao Tuqiang Chemical
7.6.1 Yuyao Tuqiang Chemical Company Information
7.6.2 Yuyao Tuqiang Chemical Introduction and Business Overview
7.6.3 Yuyao Tuqiang Chemical Dihydropyridine (DHP) Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Yuyao Tuqiang Chemical Dihydropyridine (DHP) Product Offerings
7.6.5 Yuyao Tuqiang Chemical Recent Developments
7.7 Skyrun Industrial
7.7.1 Skyrun Industrial Company Information
7.7.2 Skyrun Industrial Introduction and Business Overview
7.7.3 Skyrun Industrial Dihydropyridine (DHP) Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Skyrun Industrial Dihydropyridine (DHP) Product Offerings
7.7.5 Skyrun Industrial Recent Developments
7.8 Neostar United Industrial
7.8.1 Neostar United Industrial Company Information
7.8.2 Neostar United Industrial Introduction and Business Overview
7.8.3 Neostar United Industrial Dihydropyridine (DHP) Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Neostar United Industrial Dihydropyridine (DHP) Product Offerings
7.8.5 Neostar United Industrial Recent Developments
7.9 Haihang Industry
7.9.1 Haihang Industry Company Information
7.9.2 Haihang Industry Introduction and Business Overview
7.9.3 Haihang Industry Dihydropyridine (DHP) Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Haihang Industry Dihydropyridine (DHP) Product Offerings
7.9.5 Haihang Industry Recent Developments
8 Industry Chain Analysis
8.1 Dihydropyridine (DHP) Industrial Chain
8.2 Dihydropyridine (DHP) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Dihydropyridine (DHP) Sales Model
8.5.2 Sales Channels
8.5.3 Dihydropyridine (DHP) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Dihydropyridine (DHP) market was valued at US$ 13.57 million in 2025 and is anticipated to reach US$ 18.03 million by 2032, at a CAGR of 4.2% from 2026 to 2032.
Published Date: 2026-04-25
Pages: 130
USD 2900.00
(Single User License)
The global Dihydropyridine (DHP) market is projected to grow from US$ 13.1 million in 2024 to US$ 17.4 million by 2031, at a CAGR of 4.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-25
Pages: 146
USD 4900.00
(Single User License)
The global Dihydropyridine (DHP) market size was US$ 13.1 million in 2024 and is forecast to a readjusted size of US$ 17.4 million by 2031 with a CAGR of 4.2% during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 79
USD 4250.00
(Single User License)
The global market for Dihydropyridine (DHP) was valued at US$ 13.1 million in the year 2024 and is projected to reach a revised size of US$ 17.4 million by 2031, growing at a CAGR of 4.2% during the forecast period.
Published Date: 2025-02-21
Pages: 93
USD 2900.00
(Single User License)
The global market for Dihydropyridine (DHP) was estimated to be worth US$ 13.1 million in 2024 and is forecast to a readjusted size of US$ 17.4 million by 2031 with a CAGR of 4.2% during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 96
USD 3950.00
(Single User License)
Dihydropyridine (DHP) is a molecule based on pyridine, which is a six-membered ring with one nitrogen atom. DHP has two hydrogen atoms replacing one double bond in the ring, making it partially saturated. DHP is the parent of a class of molecules that have various substituents attached to the ring, and are widely used as L-type calcium channel blockers, which are medications that block the entry of calcium ions into the muscle cells of the heart and blood vessels, thereby lowering blood pressure and treating various cardiovascular diseases.
Published Date: 2024-04-07
Pages: 92
USD 4900.00
(Single User License)
Dihydropyridine (DHP) is a molecule based on pyridine, which is a six-membered ring with one nitrogen atom. DHP has two hydrogen atoms replacing one double bond in the ring, making it partially saturated. DHP is the parent of a class of molecules that have various substituents attached to the ring, and are widely used as L-type calcium channel blockers, which are medications that block the entry of calcium ions into the muscle cells of the heart and blood vessels, thereby lowering blood pressure and treating various cardiovascular diseases.
Published Date: 2024-01-31
Pages: 86
USD 2900.00
(Single User License)
The global Dihydropyridine (DHP) market was valued at US$ 13.57 million in 2025 and is anticipated to reach US$ 18.03 million by 2032, at a CAGR of 4.2% from 2026 to 2032.
Published: 2026-04-25
Pages: 130
The global Dihydropyridine (DHP) market is projected to grow from US$ 13.1 million in 2024 to US$ 17.4 million by 2031, at a CAGR of 4.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-25
Pages: 146
The global Dihydropyridine (DHP) market size was US$ 13.1 million in 2024 and is forecast to a readjusted size of US$ 17.4 million by 2031 with a CAGR of 4.2% during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 79
The global market for Dihydropyridine (DHP) was valued at US$ 13.1 million in the year 2024 and is projected to reach a revised size of US$ 17.4 million by 2031, growing at a CAGR of 4.2% during the forecast period.
Published: 2025-02-21
Pages: 93
The global market for Dihydropyridine (DHP) was estimated to be worth US$ 13.1 million in 2024 and is forecast to a readjusted size of US$ 17.4 million by 2031 with a CAGR of 4.2% during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 96
Dihydropyridine (DHP) is a molecule based on pyridine, which is a six-membered ring with one nitrogen atom. DHP has two hydrogen atoms replacing one double bond in the ring, making it partially saturated. DHP is the parent of a class of molecules that have various substituents attached to the ring, and are widely used as L-type calcium channel blockers, which are medications that block the entry of calcium ions into the muscle cells of the heart and blood vessels, thereby lowering blood pressure and treating various cardiovascular diseases.
Published: 2024-04-07
Pages: 92
Dihydropyridine (DHP) is a molecule based on pyridine, which is a six-membered ring with one nitrogen atom. DHP has two hydrogen atoms replacing one double bond in the ring, making it partially saturated. DHP is the parent of a class of molecules that have various substituents attached to the ring, and are widely used as L-type calcium channel blockers, which are medications that block the entry of calcium ions into the muscle cells of the heart and blood vessels, thereby lowering blood pressure and treating various cardiovascular diseases.
Published: 2024-01-31
Pages: 86
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now